BAUSCH & LOMB INC
10-Q, EX-11, 2000-08-07
OPHTHALMIC GOODS
Previous: BAUSCH & LOMB INC, 10-Q, 2000-08-07
Next: BAUSCH & LOMB INC, 10-Q, EX-27, 2000-08-07

 

 

Bausch & Lomb Incorporated

Exhibit 11

 

Statement Regarding Computation of Per Share Earnings

(Share Amounts in Thousands Except Per Share Data)

 

   

Three Months Ended

 

Six Months Ended

   

June 24,

 

June 26,

 

June 24,

 

June 26,

   

2000

 

1999

 

2000

 

1999

Earnings (in millions)

   Earnings from continuing operations (a)

 

$34.6

 

$ 28.9

 

$73.8 

 

$ 43.9

   Earnings from discontinued operations

      (see Footnote 1) (b)

 

-

 

144.5

 

-

 

151.9

   Net earnings

 

$34.6

 

$173.4

 

$73.8 

 

$195.8

                 

Actual outstanding Common and Class B shares at beginning of period

 

53,077

 

57,044

 

57,376 

 

56,529

                 

Sum of weighted average activity of    Common and Class B shares issued for    stock options, restricted stock awards

   and cancellations, and net activity of

   shares held in deferred compensation plan

 

 

 

 

67

 

 

 

 

236

 

 

 

 

(2,458)

 

 

 

 

473

                 

Weighted Basic Shares (c)

 

53,144

 

57,280

 

54,918 

 

57,002

                 

Effect of assumed exercise of

               

   Common stock equivalents

 

866

 

1,767

 

856 

 

1,553

                 

Weighted diluted shares (d)

54,010

59,047

55,774 

58,555

Basic Earnings Per Share:

   Continuing Operations (a/c)

$.65

$0.50

$1.34 

$0.77

   Discontinued Operations (b/c)

-

2.53

2.66

   Net Earnings

$.65

$3.03

$1.34 

$3.43

Diluted Earnings Per Share:

   Continuing Operations (a/d)

$.64

$0.49

$1.32

$0.75

   Discontinued Operations (b/d)

-

2.45

-

2.59

   Net Earnings

$.64

$2.94

$1.32

$3.34

1    Includes after-tax gain on disposal of discontinued operations.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission